Vaccine News and Research

Latest Vaccine News and Research

Monovalent COVID-19 booster vaccinations administered in early pregnancy not linked with miscarriage

HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent COVID-19 booster vaccinations administered in early pregnancy (before 20 weeks' gestation) were not associated with miscarriage.

19 May 2023

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

Researchers demonstrated the production of cross-clade neutralizing antibodies in response to EV-D68.

19 May 2023

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Research discusses the emergence of a highly diversified SARS-CoV-2 Omicron subvariant called XBB, which is spreading rapidly around the world. XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1, during the summer of 2022.

18 May 2023

Mouse study offers clues to developing an effective vaccine for Klebsiella bacteria

A mouse study at Washington University School of Medicine in St. Louis points to data that could be key to developing an effective vaccine for the bacterium Klebsiella pneumoniae.

18 May 2023

Precise control and prevention of echinococcosis in China

Announcing a new article publication for Zoonoses journal. As a zoonotic parasitic disease, echinococcosis is a severe global public health issue caused by the larvae of Echinococcus spp.

18 May 2023

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Researchers generated six human monoclonal antibodies that prevented infection.

17 May 2023

Are masks effective in the protection against COVID-19?

Researchers discussed the efficacy of masks in preventing coronavirus disease 2019 (COVID-19).

17 May 2023

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Patients with cancer whose immune systems are being supported or rebuilt by bone marrow transplantation should begin receiving vaccines for protection against SARS-CoV-2 three months post-transplant, according to a large, prospective, observational study led collaboratively by the Center for International Blood and Marrow Transplant Research, the Blood & Marrow Transplant Clinical Trials Network and Fred Hutchinson Cancer Center.

16 May 2023

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

Researchers investigated the genetic origin, distribution patterns, and antigenicity of novel AIVs.

16 May 2023

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Research highlights the effectiveness of serosurveillance in monitoring SARS-CoV-2 exposure within a population. It emphasizes the importance of considering demographic variations in antibody prevalence to inform targeted public health strategies.

16 May 2023

Obesity undermines COVID-19 vaccines

Researchers examine the impact of obesity on COVID-19 outcomes and the effectiveness of vaccines in individuals with obesity. Using data from Scotland, the study explores the relationship between body mass index (BMI) and hospitalization/mortality due to COVID-19.

15 May 2023

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.

15 May 2023

Study indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescents

Researchers discussed the presence of persistent humoral immunity among children and adolescents during COVID-19.

15 May 2023

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Previous
1
...
74
75
76
77
78
79
80
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Monovalent COVID-19 booster vaccinations administered in early pregnancy not linked with miscarriage

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Mouse study offers clues to developing an effective vaccine for Klebsiella bacteria

Precise control and prevention of echinococcosis in China

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Are masks effective in the protection against COVID-19?

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Obesity undermines COVID-19 vaccines

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

Study indicates that the Omicron wave and the rollout of vaccines led to almost 100% seropositivity and boosted anti-spike IgG titers in children and adolescents

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

SARS-CoV-2 variants show altered glycan processing

Newly identified biomarker may predict NSCLC patients' treatment response to chemoimmunotherapy

Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecoviruses

COVID-19 that occurs after vaccination carries a much lower risk of severe illness

People with obesity may need more frequent booster vaccines to maintain their immunity

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in